Skip to Content
Merck
All Photos(1)

Key Documents

PROTBA

Millipore

ProteoPrep® Blue Albumin & IgG Depletion Kit

Sign Into View Organizational & Contract Pricing


About This Item

UNSPSC Code:
41106500
NACRES:
NA.56

shipped in

ambient

Quality Level

storage temp.

2-8°C

Application

ProteoPrep® Blue Albumin & IgG Depletion Kit has been used:
  • to deplete serum samples from immunoglobulin (Ig) G and albumin
  • for albumin removal
  • for albumin and IgG removal
  • to deplete abundant plasma proteins for two-dimensional electrophoresis

Biochem/physiol Actions

ProteoPrep blue albumin depletion kit is designed to specifically remove albumin and IgG from 25 samples of human serum (25μL to 100μL) in preparation for two-dimensional electrophoresis (2DE). Albumin-depleted serum samples generated by this kit are in urea rather than salt-based buffers with little dilution, eliminating the need to precipitate the sample prior to performing 2DE.

Legal Information

ProteoPrep is a registered trademark of Merck KGaA, Darmstadt, Germany

Signal Word

Danger

Hazard Classifications

Acute Tox. 4 Oral - Aquatic Chronic 2 - Carc. 2 - Eye Dam. 1 - Flam. Liq. 3 - Repr. 2 - STOT SE 1

Target Organs

Eyes,Central nervous system

Storage Class Code

3 - Flammable liquids


Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Anna Tomascova et al.
General physiology and biophysics, 38(4), 305-314 (2019-06-21)
Blood biomarkers are usually present in low concentration and can be masked by the high-abundance proteins, of which albumin is the predominant one. The purpose of this study was to compare four different albumin removal methods compatible with in-gel based
Zeyu Sun et al.
Theranostics, 9(4), 1200-1214 (2019-03-15)
Chronic HBV infection (CHB) can lead to acute-on-chronic liver failure (HBV-ACLF) characterized by high mortality. This study aimed to reveal ACLF-related proteomic alterations, from which protein based diagnostic and prognostic scores for HBV-ACLF were developed. Methods: Ten healthy controls, 16
Xi Liang et al.
Life science alliance, 4(10) (2021-08-26)
Sepsis is defined as an organ dysfunction syndrome and it has high mortality worldwide. This study analysed the proteome of serum from patients with sepsis to characterize the pathological mechanism and pathways involved in sepsis. A total of 59 patients
Yiting Li et al.
Methods in molecular biology (Clifton, N.J.), 818, 81-96 (2011-11-16)
The development of a sensitive, specific, and non-invasive approach for cancer detection will facilitate early detection and, hence, improve the outcome of individuals with known cancer predispositions. Proteomic profiling of blood emerges to be a logical choice of such non-invasive
Daxian Wu et al.
The Journal of clinical investigation, 130(4), 2069-2080 (2020-03-17)
BACKGROUNDHBV-related acute-on-chronic liver failure (HBV-ACLF) is hallmarked by high short-term mortality rates, calling for accurate prognostic biomarkers for initial risk stratification.METHODSThree tandem mass tag-labeled (TMT-labeled) quantitative proteomic studies were performed on 10 patients with HBV-related acute hepatic decompensation and on

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service